Related references
Note: Only part of the references are listed.Orally bioavailable imidazoazepanes as calcitonin gene-related peptide (CGRP) receptor antagonists: Discovery of MK-2918
Daniel V. Paone et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men
Bart J. Van der Schueren et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
Hans-Christoph Diener et al.
CEPHALALGIA (2011)
Possible site of action of CGRP antagonists in migraine
Peer Tfelt-Hansen et al.
CEPHALALGIA (2011)
Pathophysiology of medication overuse headache: Insights and hypotheses from preclinical studies
Ian D. Meng et al.
CEPHALALGIA (2011)
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
David J. Hewitt et al.
CEPHALALGIA (2011)
Long-Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial
Kathryn M. Connor et al.
HEADACHE (2011)
Excellent Tolerability But Relatively Low Initial Clinical Efficacy of Telcagepant in Migraine
Peer Tfelt-Hansen
HEADACHE (2011)
Randomized Controlled Study of Telcagepant Plus Ibuprofen or Acetaminophen in Migraine
David J. Hewitt et al.
HEADACHE (2011)
Calcitonin Gene-Related Peptide Does Not Cause Migraine Attacks in Patients With Familial Hemiplegic Migraine
Jakob M. Hansen et al.
HEADACHE (2011)
Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment
Peer Tfelt-Hansen
JOURNAL OF HEADACHE AND PAIN (2011)
Chronic migraine plus medication overuse headache: two entities or not?
Andrea Negro et al.
JOURNAL OF HEADACHE AND PAIN (2011)
Evidence for CGRP re-uptake in rat dura mater encephali
Saurabh Gupta et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Randomized, controlled trial of telcagepant over four migraine attacks
Andrew P. Ho et al.
CEPHALALGIA (2010)
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
Jakob Moller Hansen et al.
CEPHALALGIA (2010)
A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches
Oliver Summ et al.
JOURNAL OF HEADACHE AND PAIN (2010)
Neurogenic inflammation: a study of rat trigeminal ganglion
Kim Anker Kristiansen et al.
JOURNAL OF HEADACHE AND PAIN (2010)
Pharmacological Properties of MK-3207, a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist
Christopher A. Salvatore et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers
M. S. Asghar et al.
NEUROLOGY (2010)
DIFFERENTIAL DISTRIBUTION OF CALCITONIN GENE-RELATED PEPTIDE AND ITS RECEPTOR COMPONENTS IN THE HUMAN TRIGEMINAL GANGLION
S. Eftekhari et al.
NEUROSCIENCE (2010)
Crystal Structure of the Ectodomain Complex of the CGRP Receptor, a Class-B GPCR, Reveals the Site of Drug Antagonism
Ernst ter Haar et al.
STRUCTURE (2010)
Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist
Ian M. Bell et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Elevated Saliva Calcitonin Gene-Related Peptide Levels During Acute Migraine Predict Therapeutic Response to Rizatriptan
Roger K. Cady et al.
HEADACHE (2009)
Future drugs for migraine
Ivano Farinelli et al.
INTERNAL AND EMERGENCY MEDICINE (2009)
Randomized, controlled trial of telcagepant for the acute treatment of migraine
K. M. Connor et al.
NEUROLOGY (2009)
Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells
Jing Li et al.
BRAIN RESEARCH (2008)
Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients
L. H. Lassen et al.
JOURNAL OF HEADACHE AND PAIN (2008)
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho et al.
LANCET (2008)
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
T. W. Ho et al.
NEUROLOGY (2008)
Pharmacological characterization of MK-0974 [N-[(3R, 6S)-6(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b] pyridin-1-yl)piperidine-1-carboxamide], a potent and orally Active calcitonin gene-related peptide receptor antagonist for the treatment of migraine
Christopher A. Salvatore et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine:: Discovery of N-[(3R,6S)-6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide (MK-0974)
Daniel V. Paone et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Caprolactams as potent CGRP receptor antagonists for the treatment of migraine
Anthony W. Shaw et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
The calcitonin gene-related peptide (CGR-P) receptor antagonist BIBN4096BS reduces neurogenic increases in dural blood flow
Markus Troeltzsch et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Identification of novel, orally bioavailable spirohydantoin CGRP receptor antagonists
Ian M. Bell et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors -: The role of receptor activity modifying protein 1
Debbie L. Hay et al.
MOLECULAR PHARMACOLOGY (2006)
Benzodiazepine calcitonin gene-related peptide (CGRP) receptor antagonists: Optimization of the 4-substituted piperidine
Christopher S. Burgey et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone lead
TM Williams et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor
CA Salvatore et al.
BIOCHEMISTRY (2006)
No increase of calcitonin gene-related peptide in jugular blood during migraine
JF Tvedskov et al.
ANNALS OF NEUROLOGY (2005)
The nonpeptide calcitonin gene-related peptide receptor antagonist BIBN4096BS lowers the activity of neurons with meningeal input in the rat spinal trigeminal nucleus
MJM Fischer et al.
JOURNAL OF NEUROSCIENCE (2005)
Neurobiology in primary headaches
L Edvinsson et al.
BRAIN RESEARCH REVIEWS (2005)
The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1
LM Ittner et al.
BIOCHEMISTRY (2005)
The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers
KA Petersen et al.
CEPHALALGIA (2005)
An examination of neurogenic mechanisms involved in mustard oil-induced inflammation in the mouse
AD Grant et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches
PJ Goadsby
DRUGS (2005)
Consensus statement:: Cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine
D Dodick et al.
HEADACHE (2004)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Calcitonin gene-related peptide and its role in migraine pathophysiology
U Arulmani et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Safety, tolerability and pharmacokinetics of BIBN4096BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers
M Iovino et al.
CEPHALALGIA (2004)
Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache
L Edvinsson
CEPHALALGIA (2004)
Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat
KA Petersen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release
G Juhasz et al.
PAIN (2003)
Effects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigs
K Kapoor et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynarnic responses in the pig
K Kapoor et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Identification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificity
K Kuwasako et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Migraine headache recurrence:: Relationship to clinical, pharmacological, and pharmacokinetic properties of triptans
G Géraud et al.
HEADACHE (2003)
The neuronal versus vascular hypothesis of migraine and cortical spreading depression
AA Parsons et al.
CURRENT OPINION IN PHARMACOLOGY (2003)
The extreme N-terminus of the calcitonin-like receptor contributes to the selective interaction with adrenomedullin or calcitonin gene-related peptide
D Koller et al.
FEBS LETTERS (2002)
Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists
JJ Mallee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Drug therapy: Migraine - Current understanding and treatment.
PJ Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment
MJ Moreno et al.
NEUROPHARMACOLOGY (2002)
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment:: a meta-analysis of 53 trials
MD Ferrari et al.
LANCET (2001)
Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1), and β-arrestin
S Hilaire et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Glycosylation of human CRLR at Asn123 is required for ligand binding and signaling
S Kamitani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2001)
Neurogenic inflammation in the context of migraine
DJ Williamson et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2001)
Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache - Therapeutic implications
L Edvinsson
CNS DRUGS (2001)
Plasma levels of calcitonin gene-related peptide in chronic tension-type headache
M Ashina et al.
NEUROLOGY (2000)
Share Paper
